2007Unpublished venueRequires access

Cell cycle related protein in non-small cell lung cancer

Wang Zuyi

Open publisher page 0 citations

Abstract

Objective: To investigate the cell cycle related proteins p53 and p16 in non-small cell lung cancer(NSCLC) and evaluate their correlation with clinicopathological factors.Methods: Total of 80 cases of NSCLC specimens were studied for expression of p53 and p16 by immunohistochemical technique SP method.Results: Forty-four(55%) and thirty-three(41.25%) of 80 patients revealed aberrant immunostaining p53 and p16 respectively.While 66 cases showed that at least one gene with abnormal protein expression.There was no correlation of p53 or p16 expression with the clinicopathologic features except the loss of p16 expression was significantly greater in squamous cell carcinoma than in adenocarcinoma cases.Conclusion: The results suggest that abnormal expression of cell cycle related proteins p53 and p16 is common in lung cancer and the disruption of p53/p21and pRb/p16 pathways plays an significant role in NSCLC tumorigenesis..Further studies are needed to confirm the role of p53 and p16 in the biologic behavior of the tumor.

About this research paper

What this paper is about

Objective: To investigate the cell cycle related proteins p53 and p16 in non-small cell lung cancer(NSCLC) and evaluate their correlation with clinicopathological factors.Methods: Total of 80 cases of NSCLC specimens were studied for expression of p53 and p16 by immunohistochemical technique SP method.Results: Forty-four(55%) and thirty-three(41.25%) of 80 patients revealed aberrant immunostaining p53 and p16 respectively.While 66 cases showed that at least one gene with abnormal protein expression.There was no correlation of p53 or p16 expression with the clinicopathologic features except the loss of p16 expression was significantly greater in squamous cell carcinoma than in adenocarcinoma cases.Conclusion: The results suggest that abnormal expression of cell cycle related proteins p53 and p16 is common in lung cancer and the disruption of p53/p21and pRb/p16 pathways plays an significant role in NSCLC tumorigenesis..Further studies are needed to confirm the role of p53 and p16 in the biologic behavior of the tumor.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the cell cycle related proteins p53 and p16 in non-small cell lung cancer(NSCLC) and evaluate their correlation with clinicopathological factors.Methods: Total of 80 cases of NSCLC specimens were studied for expression of p53 and p16 by immunohistochemical technique SP method.Results: Forty-four(55%) and thirty-three(41.25%) of 80 patients revealed aberrant immunostaining p53 and p16 respectively.While 66 cases showed that at least one gene with abnormal protein expression.There was no correlation of p53 or p16 expression with the clinicopathologic features except the loss of p16 expression was significantly greater in squamous cell carcinoma than in adenocarcinoma cases.Conclusion: The results suggest that abnormal expression of cell cycle related proteins p53 and p16 is common in lung cancer and the disruption of p53/p21and pRb/p16 pathways plays an significant role in NSCLC tumorigenesis..Further studies are needed to confirm the role of p53 and p16 in the biologic behavior of the tumor.

Key concepts: Carcinogenesis, Immunohistochemistry, Cell cycle, Lung cancer, Immunostaining, Adenocarcinoma, Cancer research, Cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Cell cycle related protein in non-small cell lung cancer — Research Paper | ScholarLens